Related references
Note: Only part of the references are listed.Early changes in the circulating T cells are associated with clinical outcomes after PD-L1 blockade by durvalumab in advanced NSCLC patients
Elliot Naidus et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III Trial
Wen-Zhao Zhong et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Genomic signatures define three subtypes of EGFR-mutant stage II-III non-small-cell lung cancer with distinct adjuvant therapy outcomes
Si-Yang Liu et al.
NATURE COMMUNICATIONS (2021)
Increased coexpression of PD-L1 and TIM3/TIGIT is associated with poor overall survival of patients with esophageal squamous cell carcinoma
Peipei Wang et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Identification of antigen-specific TCR sequences based on biological and statistical enrichment in unselected individuals
Neal P. Smith et al.
JCI INSIGHT (2021)
The importance of genomic predictors for clinical outcome of hematological malignancies
Cunte Chen et al.
BLOOD SCIENCE (2021)
Compartmental Analysis of T-cell Clonal Dynamics as a Function of Pathologic Response to Neoadjuvant PD-1 Blockade in Resectable Non-Small Cell Lung Cancer
Jiajia Zhang et al.
CLINICAL CANCER RESEARCH (2020)
Detection of neoantigen-reactive T cell clones based on the clonal expansion using next-generation sequencing of T cell receptor β complementarity-determining region 3
Hidetoshi Sumimoto et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2020)
TCR Repertoire Diversity of Peripheral PD-1+CD8+ T Cells Predicts Clinical Outcomes after Immunotherapy in Patients with Non-Small Cell Lung Cancer
Jiefei Han et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Predominance of Central Memory T Cells with High T-Cell Receptor Repertoire Diversity is Associated with Response to PD-1/PD-L1 Inhibition in Merkel Cell Carcinoma
Ivelina Spassova et al.
CLINICAL CANCER RESEARCH (2020)
Investigation of Antigen-Specific T-Cell Receptor Clusters in Human Cancers
Hongyi Zhang et al.
CLINICAL CANCER RESEARCH (2020)
Comprehensive T cell repertoire characterization of non-small cell lung cancer
Alexandre Reuben et al.
NATURE COMMUNICATIONS (2020)
Recent insights of T cell receptor-mediated signaling pathways for T cell activation and development
Jeong-Ryul Hwang et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
Combination of PD-L1 and PVR determines sensitivity to PD-1 blockade
Bo Ryeong Lee et al.
JCI INSIGHT (2020)
Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer
Yi-Long Wu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Profiling the pattern of the human T-cell receptor γδ complementary determinant region 3 repertoire in patients with lung carcinoma via high-throughput sequencing analysis
Hui Chen et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2019)
Comparing and contrasting predictive biomarkers for immunotherapy and targeted therapy of NSCLC
D. Ross Camidge et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Immune receptor repertoires in pediatric and adult acute myeloid leukemia
Jian Zhang et al.
GENOME MEDICINE (2019)
T cell receptor-engineered T cells for leukemia immunotherapy
Yikai Zhang et al.
CANCER CELL INTERNATIONAL (2019)
Characteristics and prognostic significance of profiling the peripheral blood T-cell receptor repertoire in patients with advanced lung cancer
Yang-Yang Liu et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
SELECT: A Phase II Trial of Adjuvant Erlotinib in Patients With Resected Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer
Nathan A. Pennell et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Ushering in Integrated T Cell Repertoire Profiling in Cancer
Ning Jiang et al.
TRENDS IN CANCER (2019)
Identification of TCR V11-2-D1-J1-1 T cell clone specific for WT1 peptides using high-throughput TCR gene sequencing
Yikai Zhang et al.
BIOMARKER RESEARCH (2019)
Interactions between EGFR and PD-1/PD-L1 pathway: Implications for treatment of NSCLC
Xue Li et al.
CANCER LETTERS (2018)
An Isolated TCR ab Restricted by HLA-A*02:01/CT37 Peptide Redirecting CD8+ T Cells To Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines
Pedro O. Flores-Villanueva et al.
JOURNAL OF IMMUNOLOGY (2018)
Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II-IIIA (N1-N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study
Wen-Zhao Zhong et al.
LANCET ONCOLOGY (2018)
Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy
Aurelie Durgeau et al.
FRONTIERS IN IMMUNOLOGY (2018)
Erlotinib versus vinorelbine plus cisplatin as adjuvant therapy in Chinese patients with stage IIIA EGFR mutation-positive non-small-cell lung cancer (EVAN) a randomised, open-label, phase 2 trial
Dongsheng Yue et al.
LANCET RESPIRATORY MEDICINE (2018)
TCR Repertoire as a Novel Indicator for Immune Monitoring and Prognosis Assessment of Patients With Cervical Cancer
Jin-Huan Cui et al.
FRONTIERS IN IMMUNOLOGY (2018)
Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance
Whijae Roh et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
EGFR mutation correlates with uninflamed phenotype and weak immunogenicity, causing impaired response to PD-1 blockade in non-small cell lung cancer
Zhong-Yi Dong et al.
ONCOIMMUNOLOGY (2017)
Eradication of Large Solid Tumors by Gene Therapy with a T-Cell Receptor Targeting a Single Cancer-Specific Point Mutation
Matthias Leisegang et al.
CLINICAL CANCER RESEARCH (2016)
Melanoma Immunotherapy in Mice Using Genetically Engineered Pluripotent Stem Cells
Mohammad Haque et al.
CELL TRANSPLANTATION (2016)
Oligoclonal expansion of TCR Vδ T cells may be a potential immune biomarker for clinical outcome of acute myeloid leukemia
Zhenyi Jin et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
Landscape of tumor-infiltrating T cell repertoire of human cancers
Bo Li et al.
NATURE GENETICS (2016)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
Characteristics of the TCR Vβ repertoire in imatinib-resistant chronic myeloid leukemia patients with ABL mutations
Xu Ling et al.
SCIENCE CHINA-LIFE SCIENCES (2015)
Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial
Yi-Long Wu et al.
LANCET ONCOLOGY (2014)
Improved Survival with T Cell Clonotype Stability After Anti-CTLA-4 Treatment in Cancer Patients
Edward Cha et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Deep sequencing of the T-cell receptor repertoire in CD8+ T-large granular lymphocyte leukemia identifies signature landscapes
Michael J. Clemente et al.
BLOOD (2013)
Alteration of the gene expression profile of T-cell receptor αβ-modified T-cells with diffuse large B-cell lymphoma specificity
Xianfeng Zha et al.
HEMATOLOGY (2013)
Characterization of the CDR3 structure of the Vβ21 T cell clone in patients with P210BCR-ABL-positive chronic myeloid leukemia and B-cell acute lymphoblastic leukemia
Xianfeng Zha et al.
HUMAN IMMUNOLOGY (2011)
Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non-Small-Cell Lung Cancer in Asia (IPASS)
Masahiro Fukuoka et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Generation of diffuse large B cell lymphoma-associated antigen-specific Vα6/Vβ13+T cells by TCR gene transfer
Qingsong Yin et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2011)
Profiling the T-cell receptor beta-chain repertoire by massively parallel sequencing
J. Douglas Freeman et al.
GENOME RESEARCH (2009)
The many important facets of T-cell repertoire diversity
J Nikolich-Zugich et al.
NATURE REVIEWS IMMUNOLOGY (2004)
Assessment of optimal selected prognostic factors
B Lausen et al.
BIOMETRICAL JOURNAL (2004)
Share Paper
